Treatment-Heterogeneity

• Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR

  October 7, 2026

  CASPR registry analysis found no significant overall anticoagulation advantage and no treatment-effect separation by phenotypic cluster.